Gregg Stephen Sando
Directeur/Membre du Conseil chez Diagnostics for the Real World (Europe) Ltd.
Profil
Gregg Stephen Sando was the founder who started Kuur Therapeutics Ltd.
in 2006, where he served as Chief Executive Officer & Director from 2012 to 2018.
He is currently a Director at Diagnostics for the Real World (Europe) Ltd.
Mr. Sando's former position was as Chairman-Supervisory Board at Cell Medica Switzerland AG.
He received his undergraduate degree from Harvard University, his graduate degree from Imperial College London, and his MBA from The University of Chicago.
Postes actifs de Gregg Stephen Sando
| Sociétés | Poste | Début |
|---|---|---|
Diagnostics for the Real World (Europe) Ltd.
 Diagnostics for the Real World (Europe) Ltd. Miscellaneous Commercial ServicesCommercial Services Diagnostics for the Real World (Europe) Ltd. develops diagnostic tests. The firm develops cutting-edge technologies and diagnostic assays for deployment in resource poor countries primarily through patient sample testing at the point of care or near the patient. Its signal amplification technologies offer rapid and reliable tests for Chlamydia, Hepatitis and HIV. The company was founded by Helen Lee in 2002 and is headquartered in Little Chesterford, the United Kingdom. | Directeur/Membre du Conseil | - |
Anciens postes connus de Gregg Stephen Sando
| Sociétés | Poste | Fin |
|---|---|---|
Kuur Therapeutics Ltd.
 Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Fondateur | 01/08/2018 |
Cell Medica Switzerland AG
 Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Président | - |
Formation de Gregg Stephen Sando
| Imperial College London | Graduate Degree |
| The University of Chicago | Masters Business Admin |
| Harvard University | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Health Technology |
Diagnostics for the Real World (Europe) Ltd.
Diagnostics for the Real World (Europe) Ltd. Miscellaneous Commercial ServicesCommercial Services Diagnostics for the Real World (Europe) Ltd. develops diagnostic tests. The firm develops cutting-edge technologies and diagnostic assays for deployment in resource poor countries primarily through patient sample testing at the point of care or near the patient. Its signal amplification technologies offer rapid and reliable tests for Chlamydia, Hepatitis and HIV. The company was founded by Helen Lee in 2002 and is headquartered in Little Chesterford, the United Kingdom. | Commercial Services |
Cell Medica Switzerland AG
Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Health Technology |